DocSym
β
Searchsearch
Search
(J70.4) Drug-induced interstitial lung disorders, unspecified
More details coming soon
99 238 in individuals diagnosis drug-induced interstitial lung disorders, unspecified confirmed
5 233 deaths with diagnosis drug-induced interstitial lung disorders, unspecified
5% mortality rate associated with the disease drug-induced interstitial lung disorders, unspecified
Diagnosis drug-induced interstitial lung disorders, unspecified is diagnosed Men are 3.52% more likely than Women
51 367
Men receive the diagnosis drug-induced interstitial lung disorders, unspecified
2 686 (5.2 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
47 871
Women receive the diagnosis drug-induced interstitial lung disorders, unspecified
2 547 (5.3 %)Died from this diagnosis.
Risk Group for the Disease drug-induced interstitial lung disorders, unspecified - Men aged 70-74 and Women aged 80-84
In Men diagnosis is most often set at age 0-94
Less common in men the disease occurs at Age 95+Less common in women the disease occurs at Age 25-29
In Women diagnosis is most often set at age 0-24, 30-95+
Disease Features drug-induced interstitial lung disorders, unspecified
Absence or low individual and public risk
Drug-induced interstitial lung disorders, unspecified - what does this mean
Drug-induced interstitial lung disorders, unspecified occur when a person is exposed to a drug or medication that causes damage to the air sacs in their lungs, leading to difficulty breathing, coughing, and other respiratory symptoms. it can be caused by long-term use of certain medications, such as chemotherapy drugs, or by taking large doses of certain antibiotics or other drugs.
What happens during the disease - drug-induced interstitial lung disorders, unspecified
Drug-induced interstitial lung disorders are caused by an abnormal reaction of the lungs to a medication or drug. this reaction can lead to inflammation and scarring of the lung tissue, which can cause difficulty breathing, chest pain, coughing, and other symptoms. in some cases, the inflammation and scarring can be severe enough to cause permanent damage to the lungs.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Physical examination
- Chest X-ray
- Spirometry
- High Resolution Computed Tomography (HRCT)
- Bronchoscopy
- Lung biopsy
- Blood tests
- Pulmonary function tests
Treatment and Medical Assistance
Main Goal: To reduce the symptoms of Drug-induced interstitial lung disorders, unspecified.
- Discontinue the use of the offending agent.
- Prescribe corticosteroids and/or other immunosuppressive agents.
- Provide symptomatic relief, such as bronchodilators and oxygen therapy.
- Initiate pulmonary rehabilitation.
- Administer antibiotics, if indicated.
- Provide nutritional support.
- Refer to a pulmonologist for further evaluation and management.
20 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Drug-induced interstitial lung disorders, unspecified - Prevention
Drug-induced interstitial lung disorders, unspecified, can be prevented by avoiding the use of drugs that can cause these disorders. if a drug is necessary, the lowest possible dose for the shortest possible duration should be used. patients should be closely monitored for any signs or symptoms of drug-induced interstitial lung disorders.